. 1996 Jan;97(1):113-4.

Practice-based outcomes research: crucial, feasible, and neglected

J Avorn¹

Affiliations

J Avorn. Pediatrics. 1996 Jan.

. 1996 Jan;97(1):113-4.

J Avorn¹

¹ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment in

Clinical research: outlook from industry.
Echols R. Echols R. Clin Perform Qual Health Care. 1996 Apr-Jun;4(2):113-4. Clin Perform Qual Health Care. 1996. PMID: 10156942 No abstract available.
Overhauling clinical trials.
Scott CT, Baker M. Scott CT, et al. Nat Biotechnol. 2007 Mar;25(3):287-92. doi: 10.1038/nbt0307-287. Nat Biotechnol. 2007. PMID: 17344876 No abstract available.
Lessons learned from independent central review.
Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J. Ford R, et al. Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031. Eur J Cancer. 2009. PMID: 19101138
Design and analysis issues for economic analysis alongside clinical trials.
Marshall DA, Hux M. Marshall DA, et al. Med Care. 2009 Jul;47(7 Suppl 1):S14-20. doi: 10.1097/MLR.0b013e3181a31971. Med Care. 2009. PMID: 19536012 Review.
Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review.
Riner A, Chan-Tack KM, Murray JS. Riner A, et al. Postgrad Med. 2009 May;121(3):139-46. doi: 10.3810/pgm.2009.05.2014. Postgrad Med. 2009. PMID: 19491552 Review.